Podiatrists in Bensalem, PA Accepting Medicare

25 Podiatrists found. Showing 21 - 25

Dr. Mitchell D Kahn, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3554 Hulmeville Rd, Suite 104, Bensalem, PA 19020 Phone: 215-245-1818    Fax: 215-245-9129

Mitchell D Shikoff, D.P.M. Podiatrist - Primary Podiatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 5000 Bensalem Blvd, Bensalem, PA 19020 Phone: 215-638-4446    Fax: 215-638-4447

Dr. Jeanine Brinkley, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2404 Bristol Rd, Bensalem, PA 19020 Phone: 215-612-4000

Colleen Parkinson Vetti, DPM Podiatrist - Public Medicine Medicare: Accepting Medicare Assignments Practice Location: 3046 Knights Rd, Bensalem, PA 19020 Phone: 215-639-4500

Dr. Mohammad Khayrul Islam, MD, DPM Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 3554 Hulmeville Rd Ste 104, Bensalem, PA 19020 Phone: 215-245-1818    Fax: 215-245-9129

News Archive

Losartan improves effectiveness of nanotherapeutics against cancer

Low doses of an inexpensive, FDA-approved hypertension medication may improve the results of nanotherapeutic approaches to cancer treatment. In a report in the early edition of Proceedings of the National Academy of Sciences, Massachusetts General Hospital (MGH) investigators describe experiments showing that the generic drug losartan, by modifying the network of collagen fibers that characterizes most solid tumors, improved the effectiveness of two nanotherapeutics against several types of cancer.

People 85 and older with high cholesterol have reduced risk for cognitive decline, study reports

People aged 85 and older whose total cholesterol had increased from their levels at midlife had a reduced risk for marked cognitive decline, compared with those a decade younger whose cholesterol was similarly elevated, Mount Sinai researchers report in a new study.

Nanotherapeutics acquires Ramoplanin clinical program from Oscient Pharmaceuticals

Nanotherapeutics, Inc., a privately held biopharmaceutical company, announced that it has acquired in bankruptcy proceedings two late stage clinical programs: Ramoplanin from Oscient Pharmaceuticals Corporation and PRX-3140 from EPIX Pharmaceuticals, Inc.

Early diagnosis of varicose vein disease leads to simpler treatments and better outcomes

Varicose vein disease is an underappreciated and often misunderstood medical condition, causing many individuals to be misdiagnosed, mistreated - or ignored - resulting in needless suffering and complications from progressively worsening symptoms. Unfortunately, patients typically wait until the disease reaches a more difficult to treat and debilitating stage: they have lifestyle limiting pain, unsightly bulging veins and spider veins, leg swelling or skin ulceration.

Read more Medical News

› Verified 8 days ago

• 1
• 2(current)